Chiasma Inc (NASDAQ:CHMA) Sellers Decreased Their Shorts By 8.24% As Of Apr 20, 2018

April 20, 2018 - By Daniel Mitchell

Chiasma, Inc. (NASDAQ:CHMA) Corporate Logo

It was recorded a decrease on Chiasma Inc (NASDAQ:CHMA)’s shorted shares with 8.24%. FINRA announced in April CHMA’s total 133,700 shorted shares. Previously was reported down change of 8.24% from 145,700 shares. Former CHMA’s position will need 9 days to recover. It has 15,000 average volume. Chiasma Inc’s shorted shares float is 1.15%.

CHMA touched $1.55 during the last trading session after $0.1 change.Chiasma, Inc. has volume of 9,618 shares. Since April 20, 2017 CHMA has declined 14.29% and is downtrending. CHMA underperformed by 25.84% the S&P500.

Chiasma, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies using transient permeability enhancer technology platform.The firm is valued at $37.80 million. The firm offers octreotide capsules, which is in Phase III clinical trial for the treatment of acromegaly, a condition that results in the bodyÂ’s production of excess growth hormone under the MYCAPSSA name.Currently it has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.